Company Monitoring Page for Roche

latest headlines for company on cafepharma

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
Tags:
FDA, Avastin, breast cancer, Roche, Genentech
No new cost-cutting, Roche chairman pledges
Fierce Pharma
Mon, 11/14/11 - 12:24 pm
Tags:
Roche, Franz Humer
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Tags:
Roche, vismodegib, FDA, skin cancer, basal cell carcinoma, hedgehog pathway inhibitor
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
Tags:
antibodies, autoimmune disease, CNS, Roche, AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer, Merck, mAb
China Biotech Week In Review: Roche's China Strategy
Seeking Alpha
Sun, 11/6/11 - 12:43 pm
Tags:
Roche, China National Biotechnology Group, Aslan, Alios BioPharma, ImmunoBiology Ltd, Healthgen Biotechnology
Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results
Biomed Reports
Sun, 11/6/11 - 12:25 pm
Tags:
Roche, Avastin, Galena Biopharma, NeuVax, breast cancer
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Tags:
Pharmasset, hepatitis C, Ribavirin, Vertex, Abbott Laboratories, PSI-7977, JNJ, Roche, Bristol-Myers Squibb
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thu, 10/27/11 - 11:12 am
Tags:
breast cancer, physicians, Avastin, Roche, Taxol
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Tags:
Roche, Anadys, hepatitis C, ANA773, Abbott Laboratories
Roche Seeks ‘Targeted Acquisitions,’ Not Abbott-Sized Deal
Bloomberg
Fri, 10/21/11 - 10:54 am
Tags:
Severin Schwan, Roche, Abbott Laboratories, M&A, Pharma CEOs
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Tags:
Abbott Laboratories, reorganization, Amgen, Biogen Idec, Bristol-Myers Squibb, GSK, JNJ, Boston Scientific, Medtronic, Pfizer, Roche, Pharmasset
Halozyme rallies on Herceptin drug study
Marketwatch
Tue, 10/18/11 - 10:34 am
Tags:
Halozyme, Herceptin, Roche, breast cancer
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Tags:
Anadys, Roche, Merck, JNJ, Achillion, M&A, Indenix, Bristol-Myers Squibb
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Tags:
Roche, M&A, Anadys, hepatitis C, Pegasys, setrobuvir, Merck, Victrelis, RG7128, Pharmasset
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Mon, 10/17/11 - 09:27 am
Tags:
Roche, M&A, Anadys, hepatitis C
Weak cancer meds, Tamiflu take bite out of Roche sales
Fierce Pharma
Thu, 10/13/11 - 11:36 am
Tags:
Tamiflu, Roche, earnings
Roche spotlights PhI efficacy of Alzheimer's antibody
Fierce Biotech
Tue, 10/11/11 - 10:59 am
Tags:
Roche, Alzheimer's disease, gantenerumab
Spanish Drugmakers Eye $7 Billion Sale of Bonds Backed by Unpaid Bills
Bloomberg
Tue, 10/4/11 - 01:30 pm
Tags:
Spain, Novartis, Roche
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Fri, 09/30/11 - 12:03 pm
Tags:
Japan, Pfizer, Roche, Novartis
Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Mon, 09/26/11 - 11:31 am
Tags:
Roche, HDL therapy, Merck, dalcetrapib, Anacetrapib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.